September 29, 2011
AstraZeneca Pharmaceuticals Inc. announced Thursday that it had reached a settlement with rival Handa Pharmaceuticals LLC in several suits in New Jersey over Handa's bid to produce a generic version of the schizophrenia drug Seroquel XR.
March 10, 2011
AstraZeneca Pharmaceuticals Inc. moved Wednesday to block a rival from using one of its paid consultants as an expert witness in ongoing patent infringement litigation in New Jersey over a proposed generic version of schizophrenia treatment Seroquel XR.
December 10, 2008
AstraZeneca Pharmaceuticals LP has sued Handa Pharmaceuticals LLC for the third time since July over its bid to produce a generic version of Seroquel XR.
October 29, 2008
AstraZeneca Pharmaceuticals LP hit Handa Pharmaceuticals LLC with a second infringement suit in three months Tuesday over its bid to produce a generic version of Seroquel XR.
July 31, 2008
AstraZeneca Pharmaceuticals LP has sued Handa Pharmaceuticals LLC for infringement for its bid to produce a generic version of Seroquel XR.